About VitalCrowd

Ever-Evolving Collaborative Ecosytem

Vital Crowd is an experiment, driven by passion, informed by experience and catalyzed by frustration with the ‘way things work’ in health care research and design.

While more and more people are realizing that we need those who live within the confines of the health care system to participate in the design of health research, finding a way to do that has been challenging. Researchers are relying on one-off focus groups or ad hoc conversations with patients or caregivers, followed by limited opportunities to collaborate in defining the actual protocol or providing insights on methods. What’s lacking is a way to enable meaningful, ongoing collaboration between the health care community and the researchers who seek to understand it. 

VitalCrowd was created to make that collaboration possible – and scalable. Drawing on new models for crowdsourcing and Web-based collaboration, we hope to bring the full health care community – patients, caregivers, community physicians, researchers, funders and developers alike – into a collaborative, efficient tool that takes health care research where we know it needs to go.

VitalCrowd Team

Anna McCollister-Slipp
Chief Advocate for Participatory Research
Scripps Translational Science Institute

Anna McCollister-Slipp is the Chief Advocate for Participatory Research at the Scripps Translational Science Institute, where she is charged with bringing the expertise of patients, caregivers and community physicians into the design of health research. In addition, she is co-founder of Galileo Analytics, a Visual Data Exploration and advanced data analytics company focused on democratizing access to and understanding of complex health data. 

Anna’s passion for innovation in health data research is rooted in her personal experiences living with type 1 diabetes. As an entrepreneur and advocate, she speaks frequently about the promise of digital health, the imperative for patient data access and the need for improved outcomes measures for chronic disease. Anna serves on a number of government and private committees and boards aimed at promoting innovative ways to better understand, manage and treat complex health conditions, such as diabetes.

Eric Topol
Scripps Translational Science Institute
Eric Topol is a Professor of Genomics at the Scripps Research Institute, the Director of the Scripps Translational Science Institute (STSI), and the Chief Academic Officer for Scripps Health. As a researcher, he has published 1100 peer-reviewed articles, with over 160,000 citations, elected to the National Academy of Medicine, and is one of the top 10 most cited researchers in medicine (Thomson Reuters ISI, “Doctor of the Decade”). His principal scientific focus has been on the genomics of coronary artery disease and heart attack, with work that has been recognized twice as American Heart Association Top 10 Advances and as a TIME Magazine Top Medical Breakthrough in 2010. In recent years, he has expanded such research efforts with the use of genome editing, biosensors and new digital tools to foster individualized (aka “precision”) approaches in medicine.
In 2012, he was voted as the #1 most Influential physician executive in the United States in a national poll conducted by Modern Healthcare. Besides editing several textbooks, he has published 2 books: The Creative Destruction of Medicine (Basic Books, 2012) and The Patient Will See You Now in 2015.
Steve Steinhubl
Director, Digital Medicine
Scripps Translational Science Institute

Dr. Steve Steinhubl is a Professor and the Director of Digital Medicine at Scripps Translational Science Institute.  He received his undergraduate training in chemical engineering at Purdue University, graduate training in physiology at Georgetown University, and his medical degree at St. Louis University. Steve’s internal medicine residency training was completed at David Grant Medical Center at Travis Air Force Base, California. His cardiology and interventional cardiology fellowships were at the Cleveland Clinic Foundation. 

Dr. Steinhubl’s research activities have covered a broad range of topics in the treatment and prevention of cardiovascular disease, the application of integrated systems-based approaches to the optimal identification, communication and treatment of individualized risk, and most recently the clinical implementation of mobile health technologies and associated data analytics. He has been principal investigator or helped lead dozens of large-scale randomized trials and has authored over 200 peer-reviewed manuscripts as well as numerous book chapters.

Our Partners

The Scripps Translational Science Institute (STSI) aims to replace the status-quo of one-size-fits-all-medicine with individualized health care that is based on the known genetic factors influencing health and disease and that takes advantage of advances in digital technology for real-time health monitoring.
Achieve Internet is the world's leading web development firm specializing in open source back-end solutions. That's the sophisticated way of saying we've got the engineering chops to build any enterprise web and mobile solution that you can dream of.